Filing Flows › Rockwell Medical (RMTI) › Q1 2025
Rockwell Medical (RMTI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
Rockwell Medical (RMTI) reported revenue of $18.9M for the first quarter 2025 (Q1 2025), -17% from a year earlier and -23% from the quarter before. Operating margin was -7.2%, net loss $1.5M (8.0% of revenue).
Rockwell Medical, Q1 2025: revenue $18.9M (-17% year over year), operating margin -7.2%, net loss $1.5M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.9M | -23% | -17% |
| Operating profit | −$1.4M | — | — |
| Net earnings | −$1.5M | — | — |
| Operating cash flow | −$3.5M | -503% | — |
What changed
Revenue was $18.9M in Q1 2025, down 17% year over year and down 23% from the previous quarter. Concentrate Products was the largest line at 98% of revenue. Concentrate Products lost $4.1M year over year (down 18%), 108% of the total change.
Gross margin was 16.1%, up 2.6 points from a year earlier. Operating costs exceeded revenue by $1.4M, an operating margin of -7.2%. Operating expenses grew 0% against a revenue fall of 17%. The fastest-growing cost line was Sales & marketing (+20%). The quarter ended with a net loss of $1.5M, wider than the previous quarter's $756K loss.
Operating cash flow was −$3.5M. Non-cash charges added back $539K of depreciation and amortization and $445K of share-based compensation. Working capital and other items used $3.0M. Capital expenditures of $63K exceeded it, leaving free cash flow of −$3.5M.
Questions
What was Rockwell Medical's revenue in the first quarter 2025?
Rockwell Medical (RMTI) reported revenue of $18.9M for the first quarter 2025 (Q1 2025), -17% from a year earlier and -23% from the quarter before.
Was Rockwell Medical profitable in the first quarter 2025?
Operating loss was $1.4M (-7.2% of revenue) and net loss $1.5M.
Source: Rockwell Medical 10-Q on SEC EDGAR.